Andrew Brooks

Andrew I. Brooks
Andrew I. Brooks
Born	February 10, 1969; Bronxville, New York, U.S.
Died	January 23, 2021 (aged 51); New York City, U.S.
Education	University of Rochester School of Medicine (PhD);
Known for	First FDA approved COVID-19 saliva-based/home-use test;
Children	3
	Scientific career
Fields	Molecular neuroscience
Institutions	University of Medicine and Dentistry of New Jersey; RUCDR Infinite Biologics;

Andrew Ira Brooks (February 10, 1969 – January 23, 2021) was an American immunologist, academic, and businessman. He was an associate research professor at Rutgers University. He created the first FDA-approved rapid saliva test for COVID-19 diagnosis.^[1]

Brooks died on January 23, 2021 from a heart attack in New York City, aged 51.^[2]

References

↑ Buccino, Neal. Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19. Rutgers.edu (January 26, 2021). Retrieved February 1, 2021.
↑ Snyder, Alec. Andrew Brooks, who led development of the first FDA-approved Covid-19 saliva test, dies at 51. CNN (January 31, 2021). Retrieved February 1, 2021.

This short article about a person from the United States can be made longer. You can help Wikipedia by adding to it.

[Rutgers-obit-1] Buccino, Neal. Mourning the Death of Rutgers' Andrew Brooks, a Leader in the Fight Against COVID-19. Rutgers.edu (January 26, 2021). Retrieved February 1, 2021.

[2] Snyder, Alec. Andrew Brooks, who led development of the first FDA-approved Covid-19 saliva test, dies at 51. CNN (January 31, 2021). Retrieved February 1, 2021.

[1]

[2]

Andrew I. Brooks
Born	(1969-02-10)February 10, 1969 Bronxville, New York, U.S.
Died	January 23, 2021(2021-01-23) (aged 51) New York City, U.S.
Education	University of Rochester School of Medicine (PhD)
Known for	First FDA approved COVID-19 saliva-based/home-use test
Children	3
Scientific career
Fields	Molecular neuroscience
Institutions	University of Medicine and Dentistry of New Jersey RUCDR Infinite Biologics